Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Jazz Pharma Plc (JAZZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,596,733
  • Shares Outstanding, K 60,410
  • Annual Sales, $ 1,619 M
  • Annual Income, $ 487,850 K
  • 36-Month Beta 1.04
  • Price/Sales 5.89
  • Price/Cash Flow 12.12
  • Price/Book 3.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 2.98
  • Number of Estimates 2
  • High Estimate 3.07
  • Low Estimate 2.88
  • Prior Year 2.93
  • Growth Rate Est. (year over year) +1.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
154.90 +0.71%
on 10/11/18
169.82 -8.14%
on 10/01/18
-5.93 (-3.66%)
since 09/18/18
3-Month
154.90 +0.71%
on 10/11/18
181.46 -14.03%
on 08/07/18
-20.05 (-11.39%)
since 07/18/18
52-Week
128.58 +21.33%
on 11/07/17
184.00 -15.22%
on 06/20/18
+15.54 (+11.06%)
since 10/18/17

Most Recent Stories

More News
Zacks.com highlights: Manulife Financial, Jazz Pharmaceuticals, DaVita, American Axle & Manufacturing Holdings and Huntsman

Zacks.com highlights: Manulife Financial, Jazz Pharmaceuticals, DaVita, American Axle & Manufacturing Holdings and Huntsman

HUN : 22.57 (-4.32%)
AXL : 15.58 (-4.42%)
JAZZ : 156.00 (-1.80%)
MFC : 15.46 (-2.21%)
DVA : 68.95 (+0.86%)
5 Low Price-to-Book Stocks to Buy in a Volatile Market

P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

HUN : 22.57 (-4.32%)
AXL : 15.58 (-4.42%)
JAZZ : 156.00 (-1.80%)
MFC : 15.46 (-2.21%)
DVA : 68.95 (+0.86%)
JAZZ or ZTS: Which Is the Better Value Stock Right Now?

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

JAZZ : 156.00 (-1.80%)
ZTS : 91.86 (-1.00%)
Jazz Pharmaceuticals Survey Highlights Significant Impact of Excessive Daytime Sleepiness Related to Sleep Apnea

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today findings from a U.S. survey of more than 300 patients living with sleep apnea, and more than 300 partners of those with sleep apnea. An estimated...

JAZZ : 156.00 (-1.80%)
Is Jazz Pharmaceuticals a Great Stock for Value Investors?

Let's see if Jazz Pharmaceuticals (JAZZ) stock is a good choice for value-oriented investors right now from multiple angles.

JAZZ : 156.00 (-1.80%)
Is the Options Market Predicting a Spike in Jazz Pharmaceuticals (JAZZ) Stock?

Investors need to pay close attention to Jazz Pharmaceuticals (JAZZ) stock based on the movements in the options market lately.

JAZZ : 156.00 (-1.80%)
Atlantis Healthcare Wins Gold PM360 Trailblazer Award for Best Persistence/Adherence Program

Atlantis Healthcare was named a PM360 Trailblazer Gold Award winner, with Pixel Light Digital Media and Jazz Pharmaceuticals, for the Inspire+ App patient support initiative. The annual Trailblazer Awards...

JAZZ : 156.00 (-1.80%)
Jazz Pharmaceuticals Announces an Informational Webcast for Investors Related to Vyxeos EU Launch

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast to provide investors with an overview of the AML treatment landscape in the EU as well as a Vyxeos EU launch...

JAZZ : 156.00 (-1.80%)
Why Is Jazz (JAZZ) Down 2.4% Since Last Earnings Report?

Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

JAZZ : 156.00 (-1.80%)
Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor conferences.

WFC : 53.10 (-2.50%)
JAZZ : 156.00 (-1.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade JAZZ with:

Business Summary

Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and...

See More

Key Turning Points

2nd Resistance Point 164.02
1st Resistance Point 161.44
Last Price 156.00
1st Support Level 156.69
2nd Support Level 154.52

See More

52-Week High 184.00
Fibonacci 61.8% 162.83
Fibonacci 50% 156.29
Last Price 156.00
Fibonacci 38.2% 149.75
52-Week Low 128.58

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar